285 related articles for article (PubMed ID: 16305339)
1. Lactoferrin accelerates reconstitution of the humoral and cellular immune response during chemotherapy-induced immunosuppression and bone marrow transplant in mice.
Artym J; Zimecki M; Kuryszko J; Kruzel ML
Stem Cells Dev; 2005 Oct; 14(5):548-55. PubMed ID: 16305339
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory function of lactoferrin in immunosuppressed and autoimmune animals.
Zimecki M; Artym J; Chodaczek G; Kocieba M; Kuryszko J; Houszka M; Kruzel ML
Postepy Hig Med Dosw (Online); 2007; 61():283-7. PubMed ID: 17507877
[TBL] [Abstract][Full Text] [Related]
3. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
Artym J; Zimecki M; Kruzel ML
Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment.
Artym J; Zimecki M; Kruzel ML
Immunobiology; 2003; 207(3):197-205. PubMed ID: 12777061
[TBL] [Abstract][Full Text] [Related]
5. Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice.
Artym J; Zimecki M; Kruzel M
Med Sci Monit; 2004 Mar; 10(3):BR84-9. PubMed ID: 14976460
[TBL] [Abstract][Full Text] [Related]
6. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
7. Orally administered lactoferrin restores humoral immune response in immunocompromised mice.
Artym J; Zimecki M; Paprocka M; Kruzel ML
Immunol Lett; 2003 Oct; 89(1):9-15. PubMed ID: 12946859
[TBL] [Abstract][Full Text] [Related]
8. Effects of lactoferrin on IL-6 production by peritoneal and alveolar cells in cyclophosphamide-treated mice.
Artym J; Zimecki M; Kruzel ML
J Chemother; 2004 Apr; 16(2):187-92. PubMed ID: 15216955
[TBL] [Abstract][Full Text] [Related]
9. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
10. RM-11, an isoxazole derivative, accelerates restoration of the immune function in mice treated with cyclophosphamide.
Zimecki M; Artym J; Ryng S; Obmińska-Mrukowicz B
Pharmacol Rep; 2008; 60(2):183-9. PubMed ID: 18443379
[TBL] [Abstract][Full Text] [Related]
11. A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice.
Chodaczek G; Zimecki M; Lukasiewicz J; Lugowski C
Med Microbiol Immunol; 2006 Dec; 195(4):207-16. PubMed ID: 16838169
[TBL] [Abstract][Full Text] [Related]
12. Effects of lactoferrin on the immune response modified by the immobilization stress.
Zimecki M; Artym J; Chodaczek G; Kocieba M; Kruzel M
Pharmacol Rep; 2005; 57(6):811-7. PubMed ID: 16382201
[TBL] [Abstract][Full Text] [Related]
13. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.
Zimecki M; Kruzel ML
Immunol Lett; 2000 Nov; 74(3):183-8. PubMed ID: 11064098
[TBL] [Abstract][Full Text] [Related]
14. Myeloablative and immunosuppressive properties of treosulfan in mice.
Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M
Exp Hematol; 2006 Jan; 34(1):115-21. PubMed ID: 16413398
[TBL] [Abstract][Full Text] [Related]
15. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
[TBL] [Abstract][Full Text] [Related]
16. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin acts on I-A and I-E/C antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit production of granulocyte-macrophage colony stimulatory factors in vitro.
Broxmeyer HE; Platzer E
J Immunol; 1984 Jul; 133(1):306-14. PubMed ID: 6144710
[TBL] [Abstract][Full Text] [Related]
18. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in the busulfan-treated rat. I. Effect of cyclophosphamide and rabbit antirat thymocyte serum as immunosuppression.
Tutschka PJ; Santos GW
Transplantation; 1975 Aug; 20(2):101-6. PubMed ID: 241143
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
